Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.26EUR
151.89 MEUR
2.19 BEUR
187.99 M
About BioMarin Pharmaceutical Inc.
Sector
Industry
CEO
Alexander Hardy
Website
Headquarters
San Rafael
Employees (FY)
3.4 K
Founded
1997
FIGI
BBG00KGDQDX6
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.
An aggregate view of professional's ratings.
Curated watchlists where 4BMRN is featured.
Frequently Asked Questions
The current price of 4BMRN is 63.74 EUR — it has decreased by −0.09% in the past 24 hours. Watch BIOMARIN PHARMACEUTICAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EUROTLX exchange BIOMARIN PHARMACEUTICAL stocks are traded under the ticker 4BMRN.
4BMRN stock has fallen by −16.37% compared to the previous week, the month change is a −23.97% fall, over the last year BIOMARIN PHARMACEUTICAL has showed a −23.57% decrease.
We've gathered analysts' opinions on BIOMARIN PHARMACEUTICAL future price: according to them, 4BMRN price has a max estimate of 124.88 EUR and a min estimate of 64.69 EUR. Watch 4BMRN chart and read a more detailed BIOMARIN PHARMACEUTICAL stock forecast: see what analysts think of BIOMARIN PHARMACEUTICAL and suggest that you do with its stocks.
4BMRN reached its all-time high on Jul 7, 2020 with the price of 114.84 EUR, and its all-time low was 58.00 EUR and was reached on Oct 3, 2019. View more price dynamics on 4BMRN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4BMRN stock is 0.09% volatile and has beta coefficient of 0.39. Track BIOMARIN PHARMACEUTICAL stock price on the chart and check out the list of the most volatile stocks — is BIOMARIN PHARMACEUTICAL there?
Today BIOMARIN PHARMACEUTICAL has the market capitalization of 12.18 B, it has decreased by −16.03% over the last week.
Yes, you can track BIOMARIN PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
BIOMARIN PHARMACEUTICAL is going to release the next earnings report on Oct 23, 2024. Keep track of upcoming events with our Earnings Calendar.
4BMRN earnings for the last quarter are 0.51 EUR per share, whereas the estimation was 0.33 EUR resulting in a 53.71% surprise. The estimated earnings for the next quarter are 0.48 EUR per share. See more details about BIOMARIN PHARMACEUTICAL earnings.
BIOMARIN PHARMACEUTICAL revenue for the last quarter amounts to 664.75 M EUR, despite the estimated figure of 619.89 M EUR. In the next quarter, revenue is expected to reach 632.44 M EUR.
4BMRN net income for the last quarter is 100.06 M EUR, while the quarter before that showed 82.17 M EUR of net income which accounts for 21.77% change. Track more BIOMARIN PHARMACEUTICAL financial stats to get the full picture.
No, 4BMRN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 19, 2024, the company has 3.40 K employees. See our rating of the largest employees — is BIOMARIN PHARMACEUTICAL on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOMARIN PHARMACEUTICAL EBITDA is 341.60 M EUR, and current EBITDA margin is 12.35%. See more stats in BIOMARIN PHARMACEUTICAL financial statements.
Like other stocks, 4BMRN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOMARIN PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOMARIN PHARMACEUTICAL technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOMARIN PHARMACEUTICAL stock shows the strong sell signal. See more of BIOMARIN PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.